Drug Type Peptide drug conjugates |
Synonyms TBR 581, TBR581 |
Target |
Action modulators |
Mechanism CD18 modulators(integrin subunit beta 2 modulators), nectin-4 modulators(Nectin-4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | South Korea | 01 Apr 2026 |





